2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow samatasvir: new trials by email Literature Review of samatasvir trials Research Report on samatasvir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005) Samatasvir, Simeprevir, Ribavirin (RBV) - Chronic Hepatitis C Virus | Phase 2 | Completed | Merck Sharp & Dohme LLC | 143 | 2013-03-01 | 2015-04-23 |
| Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001) IDX719, Placebo - Hepatitis C, Chronic | Phase 1 / Phase 2 | Completed | Merck Sharp & Dohme LLC | 130 | 2012-01-01 | 2015-04-27 |
Hepatitis C (2) · Hepatitis C, Chronic (2)